- Home
- PHAT vs ACEL Comparison
PHAT vs ACEL Comparison
Compare PHAT & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | ACEL |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 894.0M | 942.7M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PHAT | ACEL |
|---|---|---|
| Price | $13.19 | $11.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $19.83 | $14.67 |
| AVG Volume (30 Days) | ★ 958.0K | 285.8K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 42.72 | ★ 46.34 |
| EPS | N/A | ★ 0.60 |
| Revenue | ★ $175,110,000.00 | N/A |
| Revenue This Year | $93.04 | $7.07 |
| Revenue Next Year | $58.91 | $2.81 |
| P/E Ratio | ★ N/A | $19.57 |
| Revenue Growth | ★ 216.93 | N/A |
| 52 Week Low | $2.21 | $9.55 |
| 52 Week High | $18.31 | $13.31 |
Technical Indicators
Market Signals| Indicator | PHAT | ACEL |
|---|---|---|
| Relative Strength Index (RSI) | 68.54 | 64.89 |
| Support Level | $13.02 | $10.85 |
| Resistance Level | $14.37 | $12.92 |
| Average True Range (ATR) | 0.59 | 0.24 |
| MACD | 0.23 | 0.09 |
| Stochastic Oscillator | 99.17 | 93.52 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.